Year : 2016  |  Volume : 58  |  Issue : 4  |  Page : 462--466

Use of clozapine alongside chemotherapy in a treatment-resistant bipolar disorder patient with ovarian carcinoma: A case report and brief review


Ashish Pakhre, Aarya Krishnan, Raman Deep Pattanayak, Sudhir K Khandelwal 
 Department of Psychiatry, All India Institute of Medical Sciences, New Delhi, India

Correspondence Address:
Sudhir K Khandelwal
Department of Psychiatry, All India Institute of Medical Sciences, Ansari Nagar, New  Delhi  -  110  029
India

Regular monitoring of blood counts ensures the safety of clozapine use; however, certain clinical situations may pose a dilemma for management such as use of clozapine in the presence of myelosuppressive chemotherapy. Further, there is very limited literature to guide such decisions. We report a case of a clozapine-stabilized, treatment-resistant bipolar disorder patient with ovarian carcinoma requiring chemotherapy. The clinical challenges are discussed in light of a brief review of the available reports.


How to cite this article:
Pakhre A, Krishnan A, Pattanayak RD, Khandelwal SK. Use of clozapine alongside chemotherapy in a treatment-resistant bipolar disorder patient with ovarian carcinoma: A case report and brief review.Indian J Psychiatry 2016;58:462-466


How to cite this URL:
Pakhre A, Krishnan A, Pattanayak RD, Khandelwal SK. Use of clozapine alongside chemotherapy in a treatment-resistant bipolar disorder patient with ovarian carcinoma: A case report and brief review. Indian J Psychiatry [serial online] 2016 [cited 2020 Jan 28 ];58:462-466
Available from: http://www.indianjpsychiatry.org/article.asp?issn=0019-5545;year=2016;volume=58;issue=4;spage=462;epage=466;aulast=Pakhre;type=0